Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Andrew Wardley"'
Autor:
Richard Graham, Chris Plummer, Michael Stewart, David Austin, Adetayo S Kasim, Nasima Akhter, Helen C Hancock, Rebecca H Maier, Mark Verrill, Emmanuel Ogundimu, Jamie Maddox, Janine Graham, Andrew Wardley, Sophie Haney, Sharareh Vahabi, Helen Oxenham, Alison Humphreys, Nicola Cresti, Lisa Chang
Publikováno v:
BMJ Open, Vol 12, Iss 12 (2022)
Introduction Anthracyclines are included in chemotherapy regimens to treat several different types of cancer and are extremely effective. However, it is recognised that a significant side effect is cardiotoxicity; anthracyclines can cause irreversibl
Externí odkaz:
https://doaj.org/article/79a18ff071524b8a95b6238e13157b2d
Autor:
Eirini Thanopoulou, Leila Khader, Morena Caira, Andrew Wardley, Johannes Ettl, Federica Miglietta, Patrick Neven, Valentina Guarneri
Publikováno v:
Cancers, Vol 12, Iss 11, p 3317 (2020)
Enormous advances have been made in the understanding and treatment of human epidermal growth factor receptor 2-positive breast cancer (HER2+ BC) in the last 30 years that have resulted in survival gains for affected patients. A growing body of evide
Externí odkaz:
https://doaj.org/article/77d3ca4d33a140ec8276b9b53672834e
Autor:
Michail Ignatiadis, Sarah-Jane Dawson, Christos Sotiriou, Sherene Loi, Martine Piccart, Jose Baselga, Jens Huober, Wolfgang Janni, Takayuki Ueno, Andrew Wardley, Stephen Chia, Daniela Rosa, Serena Di Cosimo, Vanessa Rodrik-Outmezguine, Debora Fumagalli, Marion Maetens, Evandro de Azambuja, Ghizlane Rouas, Ian Bradburry, Christine Campbell, David Venet, Maria Joao Silva, Françoise Rothé
Forest plots for the test of association between changes between baseline and week 2 in ctDNA detection, tested either by taking differences for continuous variables or by taking subgroups of patients who had detectable ctDNA at baseline or not, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3233ec9632142ac606d2707c892ec4a
https://doi.org/10.1158/1078-0432.22470251.v1
https://doi.org/10.1158/1078-0432.22470251.v1
Autor:
Michail Ignatiadis, Sarah-Jane Dawson, Christos Sotiriou, Sherene Loi, Martine Piccart, Jose Baselga, Jens Huober, Wolfgang Janni, Takayuki Ueno, Andrew Wardley, Stephen Chia, Daniela Rosa, Serena Di Cosimo, Vanessa Rodrik-Outmezguine, Debora Fumagalli, Marion Maetens, Evandro de Azambuja, Ghizlane Rouas, Ian Bradburry, Christine Campbell, David Venet, Maria Joao Silva, Françoise Rothé
Purpose:In the neoadjuvant treatment (NAT) setting, dual HER2-targeted therapy is associated with increased pathologic complete response (pCR) rates compared with each therapy alone. Biomarkers allowing to predict treatment response during NAT are ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cdc64dda2eb2b284632c023023d7f04
https://doi.org/10.1158/1078-0432.c.6527480.v1
https://doi.org/10.1158/1078-0432.c.6527480.v1
Autor:
Michail Ignatiadis, Sarah-Jane Dawson, Christos Sotiriou, Sherene Loi, Martine Piccart, Jose Baselga, Jens Huober, Wolfgang Janni, Takayuki Ueno, Andrew Wardley, Stephen Chia, Daniela Rosa, Serena Di Cosimo, Vanessa Rodrik-Outmezguine, Debora Fumagalli, Marion Maetens, Evandro de Azambuja, Ghizlane Rouas, Ian Bradburry, Christine Campbell, David Venet, Maria Joao Silva, Françoise Rothé
Supplementary Tables
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::523468f641f6291e71e1f5146078771b
https://doi.org/10.1158/1078-0432.22470245
https://doi.org/10.1158/1078-0432.22470245
Autor:
Michail Ignatiadis, Sarah-Jane Dawson, Christos Sotiriou, Sherene Loi, Martine Piccart, Jose Baselga, Jens Huober, Wolfgang Janni, Takayuki Ueno, Andrew Wardley, Stephen Chia, Daniela Rosa, Serena Di Cosimo, Vanessa Rodrik-Outmezguine, Debora Fumagalli, Marion Maetens, Evandro de Azambuja, Ghizlane Rouas, Ian Bradburry, Christine Campbell, David Venet, Maria Joao Silva, Françoise Rothé
Supplementary materials and methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::743d26970674f2c86fb35d251731fc3d
https://doi.org/10.1158/1078-0432.22470248
https://doi.org/10.1158/1078-0432.22470248
Autor:
Eric P. Winer, Paolo Paoletti, Debasish Roychowdhury, Cristina Oliva, Denise Zembryki, Klaudia Steplewski, Bernie Dharan, Stephen D. Rubin, Joanne L. Blum, Adam Brufsky, Denise Yardley, Andrew Wardley, Stefania Gori, Sibylle Loibl, Eva Ciruelos, Richard Greil, Minetta C. Liu, Henri Roché, Hans-Joachim Stemmler, Christos Christodoulou, Dominique Lossignol, Devchand Paul, Véronique Diéras, Nancy U. Lin
Purpose: Brain metastases develop in one third of patients with advanced HER2+ breast cancer. Effective therapy for patients with central nervous system (CNS) progression after cranial radiation is extremely limited and represents a major clinical ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b28dc6c170e4838f473d40e9f1c8e4f
https://doi.org/10.1158/1078-0432.c.6517522
https://doi.org/10.1158/1078-0432.c.6517522
Autor:
Eric P. Winer, Paolo Paoletti, Debasish Roychowdhury, Cristina Oliva, Denise Zembryki, Klaudia Steplewski, Bernie Dharan, Stephen D. Rubin, Joanne L. Blum, Adam Brufsky, Denise Yardley, Andrew Wardley, Stefania Gori, Sibylle Loibl, Eva Ciruelos, Richard Greil, Minetta C. Liu, Henri Roché, Hans-Joachim Stemmler, Christos Christodoulou, Dominique Lossignol, Devchand Paul, Véronique Diéras, Nancy U. Lin
Supplementary Data from Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56d13815d0dc2df0ff0ad271f6254216
https://doi.org/10.1158/1078-0432.22440151.v1
https://doi.org/10.1158/1078-0432.22440151.v1
Autor:
Nicholas Turner, Claire Swift, Ben Jenkins, Lucy Kilburn, Maria Coakley, Matthew Beaney, Lisa Fox, Katie Goddard, Isaac Garcia-Murillas, Peter Hall, Catherine Harper-Wynne, Tamas Hickish, Sarah Kernaghan, Iain Macpherson, Alicia Okines, Carlo Palmieri, Sophie Perry, Katrina Randle, Claire Snowdon, Hilary Stobart, Andrew Wardley, Duncan Wheatley, Simon Waters, Matthew Winter, Judith Bliss
Publikováno v:
Cancer Research. 82:GS3-06
Background Detection of circulating tumour DNA (ctDNA) in patients (pts) who have completed treatment for early-stage triple negative breast cancer (TNBC) is associated with a very high risk of future relapse. Identifiying those at high risk of subse
Autor:
Iain Macpherson, Stuart McIntosh, Lucy Kilburn, Holly Tovey, Sarah Kernaghan, Katie Goddard, Indrani Bhattacharya, Clinton Boyd, Charlotte Coles, Cliona Kirwan, Mairead Mackenzie, Ciara O’Brien, Alistair Ring, Claire Snowdon, Hilary Stobart, Duncan Wheatley, Andrew Wardley, Abeer Shaaban, Peter Hall, David Cameron, Judith Bliss
Publikováno v:
Cancer Research. 82:OT2-05
Background The presence or absence of residual disease following neoadjuvant systemic anti-cancer therapy (neoSACT) for HER2-positive early breast cancer (HER2+ EBC) provides powerful prognostic information that may guide subsequent adjuvant treatmen